Infectious Diseases
Mission and Overview: Patient Care, Research and Education
The Infectious Disease (ID) Division is dedicated to the highest standards of patient care in an academic environment of education and discovery through basic and translational research and clinical investigation. The ID faculty have a broad spectrum of clinical and research expertise that provides innovative approaches to patient care in collaboration with other faculty at Loyola and physicians beyond Loyola seeking consults. Strong affiliations exist with the Department of Microbiology-Immunology through the Infectious Diseases-Immunology Institute and with the Department of Public Health Sciences to expand ID research and education to broader public health and international programs. These missions are fulfilled through programmatic integration of PharmD and Nurse Practitioner staff in an environment that fosters continuing medical education and training of Infectious Diseases Fellows, the ID experts and faculty of the future.
Clinical expertise of faculty:
- Primary care for patients with HIV/AIDS and related infections and medical problems
- Consultative care for patients with community-acquired and hospital-acquired infections and multidrug resistant infections, including those caused by MRSA and gram-negative bacteria
- Consultative care of patients with infectious diseases associated with stem cell and solid organ transplantation and hematological and other malignancies
- Consultative and primary care of patients with:
- Mycobacterial infections refractory to standard therapy (e.g. MAI/MAC, M. abscessus, etc.)
- C. difficile infections refractory to standard therapy
- Hepatitis C virus (HCV) infections in the context of liver transplantation and HIV/AIDS - Reduction and elimination of infections associated with hospitalization through surveillance, prevention, education and interventional strategies
- Increased effectiveness of hospital-based antimicrobial therapy through review and oversight of treatment strategies, education and collaboration, to provide cost-effective treatment and reduce emergence of treatment-induced antibiotic resistance
- Travel medicine recommendations and consultations
Faculty
Abdullah Chahin, MD, MA, MS
Assistant Professor
Nina Clark, MD, FIDSA
Professor and Division Director
James Cook, MD
Clinical Professor of Medicine
Anna Czapar, MD, PhD
Assistant Professor
Anna Czapar, MD, PhD
Assistant Professor
Susan Pacheco, MD
Assistant Professor
Jorge Parada, MD,MPH, FACP, FIDSA
Professor
Gail Reid, MD, MS
Assistant Professor
Rabeeya Sabzwari, MD
Assistant Professor
David Slade, MD, JD
Assistant Professor
Mission and Overview: Patient Care, Research and Education
The Infectious Disease (ID) Division is dedicated to the highest standards of patient care in an academic environment of education and discovery through basic and translational research and clinical investigation. The ID faculty have a broad spectrum of clinical and research expertise that provides innovative approaches to patient care in collaboration with other faculty at Loyola and physicians beyond Loyola seeking consults. Strong affiliations exist with the Department of Microbiology-Immunology through the Infectious Diseases-Immunology Institute and with the Department of Public Health Sciences to expand ID research and education to broader public health and international programs. These missions are fulfilled through programmatic integration of PharmD and Nurse Practitioner staff in an environment that fosters continuing medical education and training of Infectious Diseases Fellows, the ID experts and faculty of the future.
Clinical expertise of faculty:
- Primary care for patients with HIV/AIDS and related infections and medical problems
- Consultative care for patients with community-acquired and hospital-acquired infections and multidrug resistant infections, including those caused by MRSA and gram-negative bacteria
- Consultative care of patients with infectious diseases associated with stem cell and solid organ transplantation and hematological and other malignancies
- Consultative and primary care of patients with:
- Mycobacterial infections refractory to standard therapy (e.g. MAI/MAC, M. abscessus, etc.)
- C. difficile infections refractory to standard therapy
- Hepatitis C virus (HCV) infections in the context of liver transplantation and HIV/AIDS - Reduction and elimination of infections associated with hospitalization through surveillance, prevention, education and interventional strategies
- Increased effectiveness of hospital-based antimicrobial therapy through review and oversight of treatment strategies, education and collaboration, to provide cost-effective treatment and reduce emergence of treatment-induced antibiotic resistance
- Travel medicine recommendations and consultations